Evidence map›Paper›PMID 30717690›Full record

Trial reportBMC pregnancy and childbirth2019

Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial.

Ambily Jose, Reeta Mahey, Jai Bhagwan Sharma, Neerja Bhatla, Renu Saxena, Mani Kalaivani, Alka Kriplani

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC pregnancy and childbirth, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06911034 (Comparison of Ferric Carboxymaltose Versus Iron Sucrose for Treatment of Iron Deficiency Anemia in Pregnant Women), which is not on this map. Cited by 50 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06911034 phase4completednot on this mapstarted 2024, after this paper: background citation

Comparison of Ferric Carboxymaltose Versus Iron Sucrose for Treatment of Iron Deficiency Anemia in Pregnant Women

TypeinterventionalSponsorCMH Multan Institute of Medical SciencesRan2024 to 2024Enrolled60ConditionsIron Deficiency Anemia (IDA), PregnancyArmsIron Carboxymaltose, Iron Sucrose Injection
3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. A meta-analysis of ferric carboxymaltose versus other intravenous iron preparations for the management of iron deficiency anemia during pregnancy.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2024
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ambily JoseDepartment of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India.
Reeta MaheyDepartment of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India. reetamahey52@gmail.com.ORCID http://orcid.org/0000-0003-4938-4466
Jai Bhagwan SharmaDepartment of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India.
Neerja BhatlaDepartment of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India.
Renu SaxenaDepartment of Hematology, All India Institute of Medical Sciences, New Delhi, India.
Mani KalaivaniDepartment of Biostatistics, All India Institute of Medical Sciences, New Delhi, India.
Alka KriplaniDepartment of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo evaluate the efficacy and safety of intravenous Ferric Carboxymaltose. (FCM) in comparison with intravenous Iron sucrose complex (ISC) for treatment of iron deficiency anemia in pregnancy.

methodsA randomized clinical trial was conducted from (January 2016-August 2017). at a tertiary hospital. Pregnant women diagnosed with moderate to severe iron deficiency anaemia were screened for the study. One hundred patients were randomized to receive either intravenous FCM or ISC. Primary outcome was rise in hemoglobin (Hb) from baseline after 12 weeks. Secondary outcomes were change in RBC indices, serum iron studies, improvement in fatigue scores, number of visits and perinatal outcome.

resultsMean rise in Hb at 12 weeks was significantly higher in FCM group (29 g/L vs 22 g/L; p value < 0.01). FCM was associated with greater improvement in fatigue scores. Number of visits were significantly less in FCM group. No serious adverse events were noted in either group.

conclusionTreatment with FCM resulted in rapid replenishment of iron stores in pregnant women with significantly higher Hb rise over a 12 week period. The convenient dosing with lesser number of total doses to complete the treatment will lead to better compliance in community setting. CLINICAL TRIAL REGISTRATION ( WWW.CTRI.NIC.IN ): CTRI/2015/09/006224. Registered on 21/07/2017 (Trial registered retrospectively).

Indexed as

Administration, IntravenousAdultAnemia, Iron-DeficiencyErythrocyte CountFemaleFerric CompoundsFerric Oxide, SaccharatedHematinicsHemoglobinsHumansIndiaIronMaltosePregnancyPregnancy ComplicationsPrenatal Careferric carboxymaltoseFerric CompoundsFerric Oxide, SaccharatedHematinicsHemoglobinsIronMaltoseFerric carboxymaltoseIron deficiency anemiaIron sucrosePregnancy

Identifiers

PMID30717690
PMCPMC6360702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.